Anti-Rabies Serum Market Growth Forecast: Exploring Trends and Opportunities for the Next Decade
Get 15% OFF on all 2025 Global Market Reports until March 31st! Apply code FY25SAVE and grab your savings today!
What fueled the previous growth in the anti-rabies serum market?
Over the past few years, the anti-rabies serum market has seen robust growth. The market value is expected to rise from $1.42 billion in 2024 to $1.5 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.7%. This positive trajectory in the historical period is largely due to factors such as a surge in animal populations, broader vaccination plans, enhancements in diagnostic methods, amplified levels of travel and migration, escalated public health initiatives, and a higher frequency of wildlife interactions.
What will be the anti-rabies serum market size in the future?
In the approaching years, the anti-rabies serum market is predicted to experience robust growth, escalating to an estimation of $1.85 billion in 2029 with a 5.4% compound annual growth rate (CAGR). This growth for the forecasted period can be linked to the rising instances of animal bites, increased financial support for rabies study, heightened awareness about zoonotic diseases, improvements in serum storage and handling, and heightened aid for rabies control initiatives. Significant trends for the forecasted period encompass the creation of novel serum formulas, enhancements in healthcare infrastructure, technological progress in serum production, the establishment of alternative delivery systems, and the development of quick diagnostic kits.
Get your anti-rabies serum market report here!
https://www.thebusinessresearchcompany.com/report/anti-rabies-serum-global-market-report
What main drivers are fueling expansion in the anti-rabies serum market?
The escalation in cases of dog bites is anticipated to spur the expansion of the anti-rabies serum market. Dog bites encompass the injuries inflicted when a person is bitten or scratched by a dog, the severity of which can range from mild to severe. Such bites can result in infections, severe wounds, and sometimes, the transmission of illnesses such as rabies. Appropriate preventative measures and immediate medical attention are vital for controlling and reducing the risks associated with dog bites. The increase in cases of dog bites can be attributed to various factors, including urbanization that leads to increased encounters between humans and dogs, a larger population of uncontrolled or ill-trained dogs, and lack of sufficient knowledge or education about canine behavior and bite prevention. The surge in instances of dog bites has subsequently led to a higher demand for anti-rabies serum, as the serum’s prompt administration is key to halting the onset of rabies in individuals exposed to potentially infected animals. For example, in 2023, the American Veterinary Medical Association, a non-profit organization based in the US, recorded the average dog bite insurance claim cost to be $58,545. Insurers paid out $1.12B related to dog bites and other dog-associated injuries in liability claims in 2023. Dog bite claims saw a rise of roughly 10% in 2023. Hence, the increasing prevalence of dog bites is a significant factor propelling the growth of the anti-rabies serum market.
What key areas define the segmentation of the global anti-rabies serum market?
The anti-rabies serum market covered in this report is segmented –
1) By Type: Human Anti-rabies Immunoglobulin, Equine Anti-rabies Immunoglobulin
2) By Dosage And Form: Vials, Prefilled Syringes
3) By Route of Administration: Intravenous, Intramuscular
4) By End User: Hospitals, Clinics, Veterinary Hospitals
Subsegments:
1) By Human Anti-Rabies Immunoglobulin: Monovalent Human Anti-Rabies Immunoglobulin, Polyvalent Human Anti-Rabies Immunoglobulin, Intramuscular Human Anti-Rabies Immunoglobulin, Intravenous Human Anti-Rabies Immunoglobulin, Freeze-Dried Human Anti-Rabies Immunoglobulin
2) By Equine Anti-Rabies Immunoglobulin: Freeze-Dried Equine Anti-Rabies Immunoglobulin, Liquid Equine Anti-Rabies Immunoglobulin, Monovalent Equine Anti-Rabies Immunoglobulin, Polyvalent Equine Anti-Rabies Immunoglobulin
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20468&type=smp
Who are the dominant players expanding their reach in the anti-rabies serum market?
Major companies operating in the anti-rabies serum market are Merck & Co Inc., Sanofi SA, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, HCX Pharmaceuticals LLP, Intas Pharmaceuticals Ltd, Bavarian Nordic AS, Serum Institute of India Pvt Ltd., Bharat Serums And Vaccines Limited, Indian Immunologicals Ltd., Bharat Biotech., National Institute of Health Islamabad, ViNS Bioproducts Ltd., Shanghai Serum Bio-technology, Premium Serums and Vaccines Pvt Ltd ., Congruent Pharmachem, Haffkine Bio Pharmaceutical Corporation Limited, LEXICARE PHARMA PVT. LTD., Avin Darou, Central Research Institute Kasauli, Vigilomed Pharmaceuticals
How are evolving market trends shaping anti-rabies serum Strategies?
Leading entities in the anti-rabies serum market are engaging in strategic alliances to bolster their product development processes and inflate their market influence. These partnerships involve two or more companies capitalizing on each other’s strong points and resources to attain mutual advantage and prosperity. As an example, Kedrion S.p.A, a biopharmaceutical entity based in the US, entered a partnership with Kamada, an Israel-based biopharmaceutical firm, in July 2023, to distribute KEDRAB (Rabies Immune Globulin [Human]) in the United States. This collaborative effort has been pivotal in jointly developing and securing licensing for the product in the US, and in facilitating awareness about the disease. Through this, the alliance has managed to safeguard individuals who were exposed to rabid animal bites from severe and potentially fatal conditions.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20468
Which regions are emerging as leaders in the anti-rabies serum market?
North America was the largest region in the anti-rabies serum market in 2024. The regions covered in the anti-rabies serum market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Rabies Diagnostics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/rabies-diagnostics-global-market-report
Animal Therapeutics And Diagnostics Global Market Report 2025
Anti-Inflammatory Therapeutics Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
